$OMER
OMEROS CORP Stock $omer

$omer Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000143774924034903 Filed on November 13, 2024

Income Statement

Concept	2024 Q4	2024 Q3	2023 Q3
Revenue		$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin		$11.32M	$16.42M
YoY Change		-31.05%	34.63%
% of Gross Profit
Research & Development		$24.08M	$31.73M
YoY Change		-24.1%	-17.73%
% of Gross Profit
Depreciation & Amortization		$200.0K	$197.0K
YoY Change		1.52%	-38.44%
% of Gross Profit
Operating Expenses		$35.41M	$48.15M
YoY Change		-26.47%	24.85%
Operating Profit		-$35.41M	-$48.15M
YoY Change		-26.47%	-5.15%
Interest Expense		$4.052M	$7.916M
YoY Change		-48.81%	60.5%
% of Operating Profit
Other Income/Expense, Net		$2.346M	$4.413M
YoY Change		-46.84%	387.09%
Pretax Income		-$37.11M	-$51.66M
YoY Change		-28.15%	-5.72%
Income Tax
% Of Pretax Income
Net Earnings		-$32.23M	-$37.80M
YoY Change		-14.73%	116.54%
Net Earnings / Revenue
Basic Earnings Per Share		-$0.56	-$0.60
Diluted Earnings Per Share		-$0.55	-$0.60
COMMON SHARES
Basic Shares Outstanding	57.95M	57.95M	62.86M
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q3	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$123.2M	$310.3M
YoY Change	-60.31%	40.44%
Cash & Equivalents	$1.521M	$30.64M
Short-Term Investments	$121.6M	$279.7M
Other Short-Term Assets	$6.127M	$4.922M
YoY Change	24.48%	-17.73%
Inventory
Prepaid Expenses
Receivables	$35.34M	$35.89M
Other Receivables	$299.0K	$220.0K
Total Short-Term Assets	$164.9M	$351.3M
YoY Change	-53.06%	21.76%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.939M	$1.717M
YoY Change	12.93%	-92.94%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.054M	$1.054M
YoY Change	0.0%	0.0%
Total Long-Term Assets	$148.4M	$141.7M
YoY Change	4.71%	-16.14%
TOTAL ASSETS
Total Short-Term Assets	$164.9M	$351.3M
Total Long-Term Assets	$148.4M	$141.7M
Total Assets	$313.3M	$493.1M
YoY Change	-36.45%	7.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.723M	$5.866M
YoY Change	31.66%	-65.67%
Accrued Expenses	$23.25M	$34.86M
YoY Change	-33.31%	93.49%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$18.88M	$101.6M
YoY Change	-81.41%
Total Short-Term Liabilities	$55.62M	$147.2M
YoY Change	-62.21%	272.47%
LONG-TERM LIABILITIES
Long-Term Debt	$394.5M	$340.6M
YoY Change	15.84%	-22.56%
Other Long-Term Liabilities	$17.34M	$19.25M
YoY Change	-9.94%	-21.54%
Total Long-Term Liabilities	$411.9M	$359.8M
YoY Change	14.46%	-22.51%
TOTAL LIABILITIES
Total Short-Term Liabilities	$55.62M	$147.2M
Total Long-Term Liabilities	$411.9M	$359.8M
Total Liabilities	$467.5M	$507.0M
YoY Change	-7.79%	0.63%
SHAREHOLDERS EQUITY
Retained Earnings	-$879.0M	-$744.5M
YoY Change	18.07%	-2.61%
Common Stock	$724.8M	$730.5M
YoY Change	-0.78%	1.72%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$154.2M	-$13.95M
YoY Change
Total Liabilities & Shareholders Equity	$313.3M	$493.1M
YoY Change	-36.45%	7.76%

Cashflow Statement

Concept	2024 Q3	2023 Q3
OPERATING ACTIVITIES
Net Income	-$32.23M	-$37.80M
YoY Change	-14.73%	116.54%
Depreciation, Depletion And Amortization	$200.0K	$197.0K
YoY Change	1.52%	-38.44%
Cash From Operating Activities	-$32.06M	-$32.65M
YoY Change	-1.8%	23.48%
INVESTING ACTIVITIES
Capital Expenditures	$1.000K	$33.00K
YoY Change	-96.97%	1000.0%
Acquisitions
YoY Change
Other Investing Activities	$36.04M	$57.20M
YoY Change	-36.99%	73.35%
Cash From Investing Activities	$36.04M	$57.17M
YoY Change	-36.96%	73.24%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-4.579M	-483.0K
YoY Change	848.03%	-100.39%
NET CHANGE
Cash From Operating Activities	-32.06M	-32.65M
Cash From Investing Activities	36.04M	57.17M
Cash From Financing Activities	-4.579M	-483.0K
Net Change In Cash	-599.0K	24.04M
YoY Change	-102.49%	-81.71%
FREE CASH FLOW
Cash From Operating Activities	-$32.06M	-$32.65M
Capital Expenditures	$1.000K	$33.00K
Free Cash Flow	-$32.06M	-$32.68M
YoY Change	-1.9%	23.59%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-34475
	dei	Entity Registrant Name EntityRegistrantName	OMEROS CORPORATION
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	WA
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	91-1663741
	dei	Entity Address Address Line1 EntityAddressAddressLine1	201 Elliott Avenue West
	dei	Entity Address City Or Town EntityAddressCityOrTown	Seattle
	dei	Entity Address State Or Province EntityAddressStateOrProvince	WA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	98119
	dei	City Area Code CityAreaCode	206
	dei	Local Phone Number LocalPhoneNumber	676-5000
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
	dei	Trading Symbol TradingSymbol	OMER
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	57949760
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Central Index Key EntityCentralIndexKey	0001285819
	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P5Y
CY2024Q3	omer	Number Of Options To Extend Lease Term NumberOfOptionsToExtendLeaseTerm	2	pure
CY2024Q2	us-gaap	Debt Instrument Variable Interest Rate Type Extensible Enumeration DebtInstrumentVariableInterestRateTypeExtensibleEnumeration	http://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrMember
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
	dei	Document Type DocumentType	10-Q
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1521000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7105000	usd
CY2024Q3	us-gaap	Short Term Investments ShortTermInvestments	121636000	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	164743000	usd
CY2024Q3	omer	Royalty Receivable Current RoyaltyReceivableCurrent	29243000	usd
CY2023Q4	omer	Royalty Receivable Current RoyaltyReceivableCurrent	29373000	usd
CY2024Q3	us-gaap	Receivables Net Current ReceivablesNetCurrent	6394000	usd
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	8096000	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6127000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8581000	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	164921000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	217898000	usd
CY2024Q3	omer	Royalty Receivable Noncurrent RoyaltyReceivableNoncurrent	129488000	usd
CY2023Q4	omer	Royalty Receivable Noncurrent RoyaltyReceivableNoncurrent	138736000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	15933000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	18631000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1939000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1950000	usd
CY2024Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1054000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1054000	usd
CY2024Q3	us-gaap	Assets Assets	313335000	usd
CY2023Q4	us-gaap	Assets Assets	378269000	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	7723000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7712000	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	23246000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	31868000	usd
CY2024Q3	omer	Royalty Obligation Current RoyaltyObligationCurrent	18884000	usd
CY2023Q4	omer	Royalty Obligation Current RoyaltyObligationCurrent	8576000	usd
CY2024Q3	omer	Operating And Finance Lease Liability Current OperatingAndFinanceLeaseLiabilityCurrent	5770000	usd
CY2023Q4	omer	Operating And Finance Lease Liability Current OperatingAndFinanceLeaseLiabilityCurrent	5160000	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	55623000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	53316000	usd
CY2024Q3	us-gaap	Senior Long Term Notes SeniorLongTermNotes	97032000	usd
CY2023Q4	us-gaap	Senior Long Term Notes SeniorLongTermNotes	213155000	usd
CY2024Q3	us-gaap	Long Term Loans Payable LongTermLoansPayable	92427000	usd
CY2023Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	0	usd
CY2024Q3	omer	Royalty Liabilities Noncurrent RoyaltyLiabilitiesNoncurrent	205089000	usd
CY2023Q4	omer	Royalty Liabilities Noncurrent RoyaltyLiabilitiesNoncurrent	116550000	usd
CY2024Q3	omer	Lease Liabilities Noncurrent LeaseLiabilitiesNoncurrent	14242000	usd
CY2023Q4	omer	Lease Liabilities Noncurrent LeaseLiabilitiesNoncurrent	18143000	usd
CY2024Q3	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	3094000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	2088000	usd
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	57949760
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	57949760
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	61128597
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	61128597
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	579000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	611000	usd
CY2024Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	724236000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	727936000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-878987000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-753530000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-154172000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-24983000	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	313335000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	378269000	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	24084000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	31731000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	96203000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	85980000	usd
CY2024Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	11323000	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	16422000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	37395000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	38785000	usd
CY2024Q3	us-gaap	Costs And Expenses CostsAndExpenses	35407000	usd
CY2023Q3	us-gaap	Costs And Expenses CostsAndExpenses	48153000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	133598000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	124765000	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-35407000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-48153000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-133598000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-124765000	usd
CY2024Q3	us-gaap	Interest Expense InterestExpense	4052000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	7916000	usd
	us-gaap	Interest Expense InterestExpense	21498000	usd
	us-gaap	Interest Expense InterestExpense	23781000	usd
CY2024Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	2346000	usd
CY2023Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	4413000	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	9008000	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	12913000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-37113000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-51656000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-146088000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-135633000	usd
CY2024Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	4881000	usd
CY2023Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	13906000	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	20631000	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	26888000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-32232000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-37750000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-125457000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-108745000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.64
CY2023Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.82
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-2.51
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-2.16
CY2024Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.08
CY2023Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.22
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.36
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.43
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.56
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.6
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.15
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.73
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	57948093
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62856721
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	58232007
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62840990
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-24983000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	32000	usd
CY2024Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	11851000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	2658000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-37184000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-71328000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	2768000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-56041000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-124598000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	17000	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	2641000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-32232000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-154172000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	85684000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	2953000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-33701000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	54936000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	97000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	2771000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-37294000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	20510000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	53000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	3235000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-37750000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-13952000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-125457000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-108745000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	8067000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	8959000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	649000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	715000	usd
	us-gaap	Assets Fair Value Adjustment AssetsFairValueAdjustment	-12824000	usd
	us-gaap	Assets Fair Value Adjustment AssetsFairValueAdjustment	-11484000	usd
	omer	Interest On Contract Royalty Asset InterestOnContractRoyaltyAsset	7384000	usd
	omer	Interest On Contract Royalty Asset InterestOnContractRoyaltyAsset	14924000	usd
	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	4295000	usd
	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	7280000	usd
	omer	Noncash Royalty Interest NoncashRoyaltyInterest	-1553000	usd
	omer	Noncash Royalty Interest NoncashRoyaltyInterest	0	usd
	omer	Increase Decrease In Contract Royalty Asset IncreaseDecreaseInContractRoyaltyAsset	-29586000	usd
	omer	Increase Decrease In Contract Royalty Asset IncreaseDecreaseInContractRoyaltyAsset	-29900000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1790000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-876000	usd
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-1702000	usd
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-206343000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-11305000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3741000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-119823000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	109551000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	969221000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	751114000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	921819000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	839595000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	139000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	308000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	47263000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-88789000	usd
	omer	Proceeds From Sale Of Future Royalties ProceedsFromSaleOfFutureRoyalties	115525000	usd
	omer	Proceeds From Sale Of Future Royalties ProceedsFromSaleOfFutureRoyalties	0	usd
	omer	Proceeds From Stock Options And Warrants Exercised ProceedsFromStockOptionsAndWarrantsExercised	52000	usd
	omer	Proceeds From Stock Options And Warrants Exercised ProceedsFromStockOptionsAndWarrantsExercised	150000	usd
	us-gaap	Payments Of Debt Restructuring Costs PaymentsOfDebtRestructuringCosts	21179000	usd
	us-gaap	Payments Of Debt Restructuring Costs PaymentsOfDebtRestructuringCosts	-0	usd
	omer	Principal Payments On Royalty Obligations PrincipalPaymentsOnRoyaltyObligations	15125000	usd
	omer	Principal Payments On Royalty Obligations PrincipalPaymentsOnRoyaltyObligations	854000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	11851000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	-0	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	446000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	427000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	66976000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1131000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5584000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	19631000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7105000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	11009000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1521000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	30640000	usd
	us-gaap	Interest Paid Net InterestPaidNet	28122000	usd
	us-gaap	Interest Paid Net InterestPaidNet	23801000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-109000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3776000	usd
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	509000	usd
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	632000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	123200000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-119800000	usd
CY2021Q1	omer	Equity Offering Facility Maximum Aggregate Offering Amount EquityOfferingFacilityMaximumAggregateOfferingAmount	150000000	usd
CY2021Q4	omer	Percentage Of Royalty Receivable On Sale Of Product Rights PercentageOfRoyaltyReceivableOnSaleOfProductRights	0.30	pure
CY2021Q4	omer	Percentage Of Interest Earned On Outstanding Contract Royalty Asset PercentageOfInterestEarnedOnOutstandingContractRoyaltyAsset	0.11	pure
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: left; text-indent: 9pt;"><i>Financial Instruments and Concentrations of Credit Risk</i></p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:18pt;">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents and short-term investments. Cash and cash equivalents are deposited in checking and sweep accounts at financial institutions. At times, our cash and cash equivalents balance held at a financial institution may exceed the federally insured limits. To limit the credit risk, we invest our excess cash in high-quality securities such as money market mutual funds, certificates of deposit and U.S. treasury bills. The Company has not experienced any losses on its deposits of cash and cash equivalents. Management believes that the Company is not currently exposed to significant credit risk as the Company’s short-term investments are held in custody at third-party financial institutions. The Company’s investment policy limits investments to certain types of securities issued by the U.S. government, its agencies and institutions with investment-grade credit ratings and places restrictions on maturities and concentration by type and issuer. The Company is exposed to credit risk in the event of a default by the financial institutions holding its cash, cash equivalents and investments, and issuers of the investments to the extent recorded on the unaudited condensed consolidated balance sheets. As of September 30, 2024, the Company has no off-balance sheet concentrations of credit risk.</p>
CY2024Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5469535
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	17218447
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8991158
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	17221391
CY2024Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	1800000	usd
CY2023Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	4000000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	7100000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	11700000	usd
CY2024Q3	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	121636000	usd
CY2024Q3	us-gaap	Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax	4000	usd
CY2024Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	121640000	usd
CY2024Q3	us-gaap	Debt Securities Available For Sale And Held To Maturity Amortized Cost After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss	122690000	usd
CY2024Q3	us-gaap	Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax	4000	usd
CY2024Q3	us-gaap	Debt Securities Available For Sale And Held To Maturity Fair Value DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue	122694000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	164743000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax	19000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	164762000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale And Held To Maturity Amortized Cost After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAndHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss	165797000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax	19000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale And Held To Maturity Fair Value DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue	165816000	usd
CY2024Q3	omer	Royalty Receivable Current RoyaltyReceivableCurrent	29243000	usd
CY2023Q4	omer	Royalty Receivable Current RoyaltyReceivableCurrent	29373000	usd
CY2024Q3	omer	Royalty Receivable Noncurrent RoyaltyReceivableNoncurrent	129488000	usd
CY2023Q4	omer	Royalty Receivable Noncurrent RoyaltyReceivableNoncurrent	138736000	usd
CY2024Q3	omer	Contract Royalty Asset ContractRoyaltyAsset	158731000	usd
CY2023Q4	omer	Contract Royalty Asset ContractRoyaltyAsset	168109000	usd
CY2024Q3	omer	Royalty Receivable RoyaltyReceivable	6095000	usd
CY2023Q4	omer	Royalty Receivable RoyaltyReceivable	6724000	usd
CY2024Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	299000	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1372000	usd
CY2024Q3	us-gaap	Receivables Net Current ReceivablesNetCurrent	6394000	usd
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	8096000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12710000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12191000	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10771000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10241000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1939000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1950000	usd
CY2024Q3	us-gaap	Depreciation Depreciation	200000	usd
CY2023Q3	us-gaap	Depreciation Depreciation	200000	usd
	us-gaap	Depreciation Depreciation	600000	usd
	us-gaap	Depreciation Depreciation	700000	usd
CY2024Q3	omer	Accrued Clinical Trial Costs AccruedClinicalTrialCosts	8404000	usd
CY2023Q4	omer	Accrued Clinical Trial Costs AccruedClinicalTrialCosts	10168000	usd
CY2024Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6930000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	7380000	usd
CY2024Q3	omer	Accrued Contract Research Costs AccruedContractResearchCosts	4453000	usd
CY2023Q4	omer	Accrued Contract Research Costs AccruedContractResearchCosts	6223000	usd
CY2024Q3	us-gaap	Interest Payable Current InterestPayableCurrent	1356000	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	4242000	usd
CY2024Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1296000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	3539000	usd
CY2024Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	807000	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	316000	usd
CY2024Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	23246000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	31868000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	20000000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	97862000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	47077000	usd
CY2024Q3	omer	Long Term Debt Maturity After Year Four LongTermDebtMaturityAfterYearFour	0	usd
CY2024Q3	us-gaap	Long Term Debt LongTermDebt	164939000	usd
CY2024Q3	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	24520000	usd
CY2024Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	189459000	usd
CY2024Q3	omer	Royalty Obligation Principal Payments Due Next Twelve Months RoyaltyObligationPrincipalPaymentsDueNextTwelveMonths	3806000	usd
CY2024Q3	omer	Royalty Obligation Interest Payments Due Next Twelve Months RoyaltyObligationInterestPaymentsDueNextTwelveMonths	5403000	usd
CY2024Q3	omer	Royalty Obligation Payments Due Next Twelve Months RoyaltyObligationPaymentsDueNextTwelveMonths	9209000	usd
CY2024Q3	omer	Royalty Obligation Principal Payments Due Year Two RoyaltyObligationPrincipalPaymentsDueYearTwo	20546000	usd
CY2024Q3	omer	Royalty Obligation Interest Payments Due Year Two RoyaltyObligationInterestPaymentsDueYearTwo	20468000	usd
CY2024Q3	omer	Royalty Obligation Payments Due Year Two RoyaltyObligationPaymentsDueYearTwo	41014000	usd
CY2024Q3	omer	Royalty Obligation Principal Payments Due Year Three RoyaltyObligationPrincipalPaymentsDueYearThree	23778000	usd
CY2024Q3	omer	Royalty Obligation Interest Payments Due Year Three RoyaltyObligationInterestPaymentsDueYearThree	18324000	usd
CY2024Q3	omer	Royalty Obligation Payments Due Year Three RoyaltyObligationPaymentsDueYearThree	42102000	usd
CY2024Q3	omer	Royalty Obligation Principal Payments Due Year Four RoyaltyObligationPrincipalPaymentsDueYearFour	27069000	usd
CY2024Q3	omer	Royalty Obligation Interest Payments Due Year Four RoyaltyObligationInterestPaymentsDueYearFour	15875000	usd
CY2024Q3	omer	Royalty Obligation Payments Due Year Four RoyaltyObligationPaymentsDueYearFour	42944000	usd
CY2024Q3	omer	Royalty Obligation Principal Payments Due Year Five RoyaltyObligationPrincipalPaymentsDueYearFive	30711000	usd
CY2024Q3	omer	Royalty Obligation Interest Payments Due Year Five RoyaltyObligationInterestPaymentsDueYearFive	13091000	usd
CY2024Q3	omer	Royalty Obligation Payments Due Year Five RoyaltyObligationPaymentsDueYearFive	43802000	usd
CY2024Q3	omer	Royalty Obligation Principal Payments Due After Year Five RoyaltyObligationPrincipalPaymentsDueAfterYearFive	118063000	usd
CY2024Q3	omer	Royalty Obligation Interest Payments Due After Year Five RoyaltyObligationInterestPaymentsDueAfterYearFive	18672000	usd
CY2024Q3	omer	Royalty Obligation Payments Due After Year Five RoyaltyObligationPaymentsDueAfterYearFive	136735000	usd
CY2024Q3	omer	Royalty Obligation Principal Payments Due RoyaltyObligationPrincipalPaymentsDue	223973000	usd
CY2024Q3	omer	Royalty Obligation Interest Payments Due RoyaltyObligationInterestPaymentsDue	91833000	usd
CY2024Q3	omer	Royalty Obligation Payments Due RoyaltyObligationPaymentsDue	315806000	usd
CY2024Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1100000	usd
CY2024Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	1610000	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	1603000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	4822000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	4852000	usd
CY2024Q3	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	173000	usd
CY2023Q3	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	140000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	468000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	529000	usd
CY2024Q3	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	26000	usd
CY2023Q3	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	29000	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	122000	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	121000	usd
CY2024Q3	us-gaap	Variable Lease Cost VariableLeaseCost	824000	usd
CY2023Q3	us-gaap	Variable Lease Cost VariableLeaseCost	807000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	2622000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	2354000	usd
CY2024Q3	us-gaap	Sublease Income SubleaseIncome	364000	usd
CY2023Q3	us-gaap	Sublease Income SubleaseIncome	375000	usd
	us-gaap	Sublease Income SubleaseIncome	1138000	usd
	us-gaap	Sublease Income SubleaseIncome	1125000	usd
CY2024Q3	us-gaap	Lease Cost LeaseCost	2269000	usd
CY2023Q3	us-gaap	Lease Cost LeaseCost	2204000	usd
	us-gaap	Lease Cost LeaseCost	6896000	usd
	us-gaap	Lease Cost LeaseCost	6731000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	5272000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	5356000	usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	534000	usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	499000	usd
CY2024Q3	omer	Longterm Purchase Commitment Termination Fee LongtermPurchaseCommitmentTerminationFee	5600000	usd
CY2021Q1	omer	Equity Offering Facility Maximum Aggregate Offering Amount EquityOfferingFacilityMaximumAggregateOfferingAmount	150000000	usd
CY2023Q4	srt	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	50000000	usd
	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	5000000
	omer	Stock Repurchased And Retired Average Price Per Share StockRepurchasedAndRetiredAveragePricePerShare	3.3
CY2024Q1	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	3200000
CY2024Q1	omer	Stock Repurchased And Retired Average Price Per Share StockRepurchasedAndRetiredAveragePricePerShare	3.71
CY2024Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	11900000	usd
CY2024Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2641000	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3235000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8067000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8959000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	15255154
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.5
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3280500
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.13
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	16404
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	3.19
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	386181
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	6.91
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	18133069
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.41
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	6168000	usd
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	17503959
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	8.58
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P5Y10M24D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	5677000	usd
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	12133698
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	10.75
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y6M
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1421000	usd
CY2024Q3	us-gaap	Share Price SharePrice	3.97
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	5900000

Files In Submission

Name	View Source	Status
0001437749-24-034903-index-headers.html	Edgar Link	pending
0001437749-24-034903-index.html	Edgar Link	pending
0001437749-24-034903.txt	Edgar Link	pending
0001437749-24-034903-xbrl.zip	Edgar Link	pending
ex_711207.htm	Edgar Link	pending
ex_711208.htm	Edgar Link	pending
ex_711209.htm	Edgar Link	pending
ex_711210.htm	Edgar Link	pending
ex_735126.htm	Edgar Link	pending
ex_735126img001.jpg	Edgar Link	pending
ex_735126img002.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
omer-20240930.xsd	Edgar Link	pending
omer20240930_10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
omer-20240930_cal.xml	Edgar Link	unprocessable
omer-20240930_pre.xml	Edgar Link	unprocessable
omer-20240930_def.xml	Edgar Link	unprocessable
omer-20240930_lab.xml	Edgar Link	unprocessable
omer20240930_10q_htm.xml	Edgar Link	completed
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OMER
OMEROS CORP Stock $omer

2024 Q4 Form 10-Q Financial Statement

#000143774924034903 Filed on November 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OMER OMEROS CORP Stock $omer

2024 Q4 Form 10-Q Financial Statement

#000143774924034903 Filed on November 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OMER
OMEROS CORP Stock $omer